CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Dongsheng Pharmaceutical Intl Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Dongsheng Pharmaceutical Intl Co Ltd
Room10, 9th Floor, Building No.5
9 Gaoshengqiao Road
Phone: +86 1088580708p:+86 1088580708 BEIJING, BEJ  100089  China Fax: +86 1088580795f:+86 1088580795

This company ceased filing statements with the SEC on 8/9/2011.
This company is no longer actively traded on any major stock exchange.

Business Summary
Dongsheng Pharmaceutical International Co., Ltd. (Dongsheng), formerly Indestructible I, Inc., is a pharmaceutical wholesaler in the People's Republic of China, which specializes in the wholesale and distribution of high-quality, high-margin and high-demand drugs, mainly to secondary and third- tier regional drug wholesalers in China. Its major suppliers are pharmaceutical manufacturers. Its main pharmaceutical products primarily cover the therapeutic areas, such as Parkinson's disease, cardiovascular, immunology and infectious diseases. The Company's core operational subsidiary is Sichuan Xintai Pharmaceutical Co., Ltd. (Xintai). The Company's products include Ganglioside, Edaravone, Salvianolate, Sulbenicillin Injection and Imipenem/cilastatin Injection. On March 25, 2010, the Company acquired Dynamic Bhorizon Limited (DBL).
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20116/30/2010YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer XiaodongZhu 39 3/25/2010 3/25/2010
Vice President - Sales DuojiaZhang 8/19/2010 8/19/2010
Chief Development Officer DiWu 45 3/25/2010 3/25/2010
Director JieDu 46 8/1/2011 8/1/2011
Director Tsang-BinZeng 53 9/28/2010 9/28/2010

Business Names
Business Name
DNGH
Dongsheng Pharmaceutical Intl Co Ltd
INDESTRUCTIBLE 1, INC
Indestructible I, Inc.

General Information
Stock Exchange: OTC
Federal Tax Id: 026260398
Fax Number: +86 1088580795


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023